Fundz

Carlsmed, Inc. reported raising $64.5 Million in an initial SEC Form D filing, from an offering of $30 Million

PUBLIC · CARLApr 27, 2022

Amount Raised

$64.5 Million

$64.5 Million sold, per SEC Form D (first sale Apr 27, 2022)

Round Type

Venture

CarlsbadBiotechnologySoftwareScience And Engineering

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Carlsmed that raised within 45 days of this round, from Fundz verified event records.

  • SentinelOne, Inc. raised $8M (Funding Round) on May 30, 2022.
  • Classiq raised an undisclosed amount (Funding Round) on May 16, 2022.
  • Sequentify raised $7M (Funding Round) on May 10, 2022.
  • IMPLICITY raised $23M (Funding Round) on April 27, 2022.
  • Be Biopharma raised $130M (Funding Round) on April 14, 2022.
  • Ensem Therapeutics raised $67M (Series A) on April 6, 2022.

Who to call at Carlsmed, and when

A new round usually means Carlsmed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Carlsmed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Carlsmed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Carlsmed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Carlsmed

Location

1800 Aston Avenue, Suite 100

Carlsbad, California, United States

About

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery. The company’s aprevo® devices are designed to improve the standard of care for surgical treatment of patients with adult spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient. The Carlsmed® aprevo® devices are FDA cleared and have been granted FDA Breakthrough Designation, an industry first for any implanted device, and are commercially available in the U.S.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Carlsmed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts19 people are listed at Carlsmed. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Carlsmed's next move

See what Strategic adds

Carlsmed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.